Higher urinary cortisol levels associate with increased cardiovascular risk.

Haas, Andrea V; Hopkins, Paul N; Brown, Nancy J; Pojoga, Luminita H; Williams, Jonathan S; Adler, Gail K; Williams, Gordon H

Haas, Andrea V; Hopkins, Paul N; Brown, Nancy J; Pojoga, Luminita H; Williams, Jonathan S; Adler, Gail K; Williams, Gordon H.

Afiliación

Haas AV; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hopkins PN; Cardiovascular Genetics, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Brown NJ; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pojoga LH; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Williams JS; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Adler GK; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Williams GH; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Endocr Connect ; 8(6): 634-640, 2019 Jun 01.

Article en En | MEDLINE | ID: mdl-31018177

Palabras clave

Caveolin-1; Framingham risk score; cardiovascular health; cortisol

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Endocr Connect Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google